Cost-Effectiveness of Dabigatran Etexilate for the Secondary Prevention of Recurrent Deep Vein Thrombosis and Pulmonary Embolism in the United Kingdom
Abstract
Authors
S. Wolowacz J. Brockbank T.J. Sunderland A.K. Gonschior